June 15, 2023

Pfizer warns FDA of penicillin shortage

Editor's Note

Pfizer alerted the Food and Drug Administration (FDA) on June 12 that its supply of two forms of injectable penicillin—Bicillin L-A and Bicillin C-R—may run out by the end of this month, the June 13 The Hill reports.

Pfizer cited a combination of factors for the shortage, including an increase in demand and a rise in syphilis cases.

The company estimates that supplies of Bicillin C-R would run out by the third quarter of this year, and the pediatric pre-filled syringes of Bicillin L-A would run out even earlier.

Live chat by BoldChat